Mordoh J - Search Results

1

Differential lytic and agglutinating activity of the anti-Lewis(x) monoclonal antibody FC-2.15 on human polymorphonuclear neutrophils and MCF-7 breast tumor cells. In vitro and ex vivo studies.

Capurro M, Ballaré C, Bover L, Portela P, Mordoh J. Capurro M, et al. Among authors: mordoh j. Cancer Immunol Immunother. 1999 May-Jun;48(2-3):100-8. doi: 10.1007/s002620050553. Cancer Immunol Immunother. 1999. PMID: 10414463 Free PMC article.

2

Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells.

Ballaré C, Barrio M, Portela P, Mordoh J. Ballaré C, et al. Among authors: mordoh j. Cancer Immunol Immunother. 1995 Jul;41(1):15-22. doi: 10.1007/BF01788955. Cancer Immunol Immunother. 1995. PMID: 7641216 Free PMC article.

3

Description of a new monoclonal antibody, FC-2.15, reactive with human breast cancer and other human neoplasias.

Mordoh J, Leis S, Bravo AI, Podhajcer OL, Ballare C, Capurro M, Kairiyama C, Bover L. Mordoh J, et al. Int J Biol Markers. 1994 Jul-Sep;9(3):125-34. doi: 10.1177/172460089400900301. Int J Biol Markers. 1994. PMID: 7829891

4

FC-2.15, a monoclonal antibody active against human breast cancer, specifically recognizes Lewis(x) hapten.

Capurro M, Bover L, Portela P, Livingston P, Mordoh J. Capurro M, et al. Among authors: mordoh j. Cancer Immunol Immunother. 1998 Feb;45(6):334-9. doi: 10.1007/s002620050451. Cancer Immunol Immunother. 1998. PMID: 9490204 Free PMC article.

5

Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15.

Ballaré C, Portela P, Schiaffi J, Yomha R, Mordoh J. Ballaré C, et al. Among authors: mordoh j. Breast Cancer Res Treat. 1998 Jan;47(2):163-70. doi: 10.1023/a:1005949118919. Breast Cancer Res Treat. 1998. PMID: 9497104

6

Monoclonal antibody FC-5.01, directed against CD63 antigen, is internalized into cytoplasmic vesicles in the IIB-BR-G human breast cancer cell line.

Barrio MM, Portela P, Mordoh J. Barrio MM, et al. Among authors: mordoh j. Hybridoma. 1998 Dec;17(6):517-25. doi: 10.1089/hyb.1998.17.517. Hybridoma. 1998. PMID: 9890707

7

Lewis x antigen mediates adhesion of human breast carcinoma cells to activated endothelium. Possible involvement of the endothelial scavenger receptor C-type lectin.

Elola MT, Capurro MI, Barrio MM, Coombs PJ, Taylor ME, Drickamer K, Mordoh J. Elola MT, et al. Among authors: mordoh j. Breast Cancer Res Treat. 2007 Jan;101(2):161-74. doi: 10.1007/s10549-006-9286-9. Epub 2006 Jul 19. Breast Cancer Res Treat. 2007. PMID: 16850248 Free PMC article.

8

In vitro analysis of the cellular proliferative response to 17-beta-estradiol of human breast cancer.

Podhajcer OL, Bravo AI, Dain L, Guman N, Bover L, Mordoh J. Podhajcer OL, et al. Among authors: mordoh j. Cancer. 1988 May 1;61(9):1807-12. doi: 10.1002/1097-0142(19880501)61:9<1807::aid-cncr2820610914>3.0.co;2-m. Cancer. 1988. PMID: 3281743

9

[The role of SPARC gene in tumorigenic capacity of human melanoma cells].

Ledda MF, Adris S, Bover L, Bravo AL, Mordoh J, Podhajcer OL. Ledda MF, et al. Among authors: mordoh j. Medicina (B Aires). 1996;56(1):51-4. Medicina (B Aires). 1996. PMID: 8734932 Spanish.

10

Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.

Ledda MF, Adris S, Bravo AI, Bover L, Carbone C, Paleolog E, Mordoh J, Chernajovsky Y, Podhajcer OL. Ledda MF, et al. Among authors: mordoh j. Cell Mol Biol (Noisy-le-grand). 1996 Jul;42(5):769-78. Cell Mol Biol (Noisy-le-grand). 1996. PMID: 8832108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters